Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com CN

Cytokeratin 8

Catalog Number:OM629131
OM629131
Discount Price
OM629131-100ul
1~2 Week
100ul
OM629131-50ul
50ul
OM629131-20ul
20ul
1~2 Week
Product Profile
Product Name Cytokeratin 8
Antibody Type Primary Antibodies
Antigen Alias CARD2 antibody CK 8 antibody CK-8 antibody CK8 antibody CYK8 antibody CYKER antibody Cytokeratin endo A antibody Cytokeratin-8 antibody DreK8 antibody EndoA antibody K2C8 antibody K2C8_HUMAN antibody K8 antibody Keratin 8 antibody Keratin type II cytoskeletal 8 antibody Keratin, type II cytoskeletal 8 antibody Keratin-8 antibody KO antibody Krt 2.8 antibody KRT8 antibody MGC118110 antibody MGC174782 antibody MGC53564 antibody MGC85764 antibody sb:cb186 antibody Type-II keratin Kb8 antibody
Product description Cytokeratins comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells. They have been found to be useful markers of tissue differentiation, which is directly applicable to the characterization of malignant tumors. Cytokeratin 8 expression is seen in epithelium and epithelium-derived tumors. The Cytokeratin 8 and 18 pair are normally expressed in simple epithelia, but not in stratified epithelial cells. Research indicates that squamous cell carcinomas derived from stratified epithelia show abnormal expression of Cytokeratin 8 and 18, although it is not known whether these proteins contribute to the malignant phenotype of the cells. Expression of Cytokeratin 8 and 18 in oral squamous cell carcinomas is an independent prognostic marker that indicates a poor prognosis. Cytokeratin 8 expression correlates with malignancy in leukoplakia and carcinomas of the head and neck; it is expressed in all non-small-cell lung cancers. Cytokeratin 8 has been shown to possess extracellular epitopes on tumor cells, which may represent valuable targets for therapy.
Immunogen Recombinant protein within Human Cytokeratin 8 aa 380-500.
Key Feature
Clonality Polyclonal
Isotype IgG
Host Species Rabbit
Tested Applications WBICCIHCFC
WB:1:500-1:2,000:
ICC:1:50:
IHC:1:50-1:200:
FC:1:50-1:100:
Species Reactivity Human
Concentration 1mg/ml
Target Information
Alternative Names CARD2 antibody CK 8 antibody CK-8 antibody CK8 antibody CYK8 antibody CYKER antibody Cytokeratin endo A antibody Cytokeratin-8 antibody DreK8 antibody EndoA antibody K2C8 antibody K2C8_HUMAN antibody K8 antibody Keratin 8 antibody Keratin type II cytoskeletal 8 antibody Keratin
type II cytoskeletal 8 antibody Keratin-8 antibody KO antibody Krt 2.8 antibody KRT8 antibody MGC118110 antibody MGC174782 antibody MGC53564 antibody MGC85764 antibody sb:cb186 antibody Type-II keratin Kb8 antibody
Molecular Weight(MW) 53/56 kDa
Cellular Localization Cytoplasm. Nucleus.
Database Links
SwissProt ID P05787
Application

Application

Fig1: Western blot analysis of Cytokeratin 8 on K562 lysate. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody was used at a 1:2,000 dilution in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature.

Application

Fig2: ICC staining Cytokeratin 8 in LOVO cells (green). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with Cytokeratin 8 at a dilution of 1:50 for 1 hour at room temperature, washed with PBS. Alexa Fluorc™ 488 Goat anti-Rabbit IgG was used as the secondary antibody at 1/100 dilution. The nuclear counter stain is DAPI (blue).

Application

Fig3: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-Cytokeratin 8 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the antibody (ER1803-87) at 1/50 dilution, for 30 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. Counter stained with hematoxylin and mounted with DPX.

Application

Fig4: Immunohistochemical analysis of paraffin-embedded human breast cancer tissue using anti-Cytokeratin 8 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the antibody (ER1803-87) at 1/200 dilution, for 30 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. Counter stained with hematoxylin and mounted with DPX.

Application

Fig5: Immunohistochemical analysis of paraffin-embedded human kidney tissue using anti-Cytokeratin 8 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the antibody (ER1803-87) at 1/200 dilution, for 30 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. Counter stained with hematoxylin and mounted with DPX.

Application

Fig6: Flow cytometric analysis of Cytokeratin 8 was done on MCF-7 cells. The cells were fixed, permeabilized and stained with Cytokeratin 8 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). After incubation of the primary antibody on room temperature for an hour, the cells was stained with a Alexa Fluor™ 488-conjugated goat anti-Rabbit IgG Secondary antibody at 1/500 dilution for 30 minutes.
Positive Control K562, LOVO, human liver tissue, human breast cancer tissue, human kidney tissue, MCF-7.
Application Notes WB:1:500-1:2,000:
ICC:1:50:
IHC:1:50-1:200:
FC:1:50-1:100:
Additional Information
Form Liquid
Storage Instructions Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage Buffer 1*TBS (pH7.4), 1%BSA, 50%Glycerol. Preservative: 0.05% Sodium Azide.
validation
question title
question detaiil
Verification code